ALLMedicine™ Herpes Zoster Center

Apr 15th, 2021 - Acyclovir has led to the development of successful systemic therapy for herpes simplex virus and varicella-zoster virus (VZV) infection, and the use of valacyclovir and famciclovir has improved treatment. Additionally, the use of a helicase-primas...

Apr 15th, 2021 - Postherpetic neuralgia (PHN) is a painful neuropathic complication resulting from herpes zoster (HZ). The pain manifests in peripheral nerves infected by herpesviruses, mostly from reactivation of latent varicella zoster virus. Mechanistic descrip...

Apr 15th, 2021 - Acute Promyelocytic Leukemia (APL) is a unique subtype of acute myeloid leukemia that is highly responsive to minimally myelosuppressive therapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). We and others have observed a higher t...

Apr 14th, 2021 - Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United States (US) for the prevention of herpes zoster in adults aged 50 years and older. The vaccine is administered in two doses, with the second dose administration ...

Apr 14th, 2021 - Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.|2021||

Jul 19th, 2020 - Herpes zoster is an infection resulting from the reactivation of dormant varicella zoster virus (VZV) in a posterior dorsal root ganglion. It affects 50% of immunocompromised patients and, when the viral infection persists, it can lead to a proces...

Oct 28th, 2019 - Shingles (also known as herpes zoster) results from infection by the varicella zoster virus. This common virus causes chickenpox (also known as varicella), which is characterized by itchy spots on the skin that cover the whole body and usually oc...

Jul 1st, 2019 - Shingles resources and references include Shingrix and Zostavax vaccination recommendations, as well as disease- and vaccine-related resources and articles.

Jun 30th, 2019 - Learn more about shingles surveillance, including shingles hospitalizations, trends, and vaccination rates

Jun 30th, 2019 - Learn about varicella zoster virus (VZV) laboratory testing and about the CDC National VDZ Laboratory.

Apr 15th, 2021 - Acyclovir has led to the development of successful systemic therapy for herpes simplex virus and varicella-zoster virus (VZV) infection, and the use of valacyclovir and famciclovir has improved treatment. Additionally, the use of a helicase-primas...

Apr 15th, 2021 - Postherpetic neuralgia (PHN) is a painful neuropathic complication resulting from herpes zoster (HZ). The pain manifests in peripheral nerves infected by herpesviruses, mostly from reactivation of latent varicella zoster virus. Mechanistic descrip...

Apr 15th, 2021 - Acute Promyelocytic Leukemia (APL) is a unique subtype of acute myeloid leukemia that is highly responsive to minimally myelosuppressive therapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). We and others have observed a higher t...

Apr 14th, 2021 - Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United States (US) for the prevention of herpes zoster in adults aged 50 years and older. The vaccine is administered in two doses, with the second dose administration ...

Apr 14th, 2021 - Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review.|2021||

Nov 24th, 2020 - Acute complications of herpes zoster (HZ) other than post-herpetic neuralgia (PHN) are relatively common, a new study suggests. Researchers conducted a cohort study of unvaccinated immunocompetent adults with incident HZ (n=178,964) and matched to...

Sep 24th, 2020 - Question 1 of 2 Which of the following laboratory tests has the highest sensitivity, provides rapid results, and can be used to monitor treatment response when collected serially in patients with suspected herpes zoster? Your Peers Chose: VZV IgG ...

Jul 27th, 2020 - Answer 5/5 Which of the following is recommended regarding the pharmacologic treatment of RA, according to 2015 guidelines from the ACR? Your peers chose: For patients with established RA who have moderate disease activity and have never taken a d...

Jul 19th, 2020 - Herpes zoster is an infection resulting from the reactivation of dormant varicella zoster virus (VZV) in a posterior dorsal root ganglion. It affects 50% of immunocompromised patients and, when the viral infection persists, it can lead to a proces...

Jun 16th, 2020 - Many clinicians acknowledge that herpes zoster (or shingles) is not something they would wish to have, but they also seem to believe it just comes and goes. This could explain the rather low rate of vaccination since the zoster vaccine live (Zosta...